-+ 0.00%
-+ 0.00%
-+ 0.00%

ADDEX ENTERS OPTION AGREEMENT WITH SINNTAXIS FOR AN EXCLUSIVE LICENSE TO INTELLECTUAL PROPERTY COVERING THE USE OF MGLU5 INHIBITORS IN BRAIN INJURY RECOVERY

Reuters·04/30/2025 05:00:23

Please log in to view news